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Abstract. Optical coherence tomography (OCT) is used to provide anatomical information of biological systems
but can also provide functional information by characterizing the motion of intracellular structures. Dynamic light
scattering OCT was performed on intact, control MCF-7 breast cancer cells and cells either treated with pacli-
taxel to induce apoptosis or deprived of nutrients to induce oncosis. Autocorrelations (ACs) of the temporal
fluctuations of OCT intensity signals demonstrate a significant decrease in decorrelation time after 24 h in
both the paclitaxel-treated and nutrient-deprived cell groups but no significant differences between the two
groups. The acquired ACs were then used as input for the CONTIN deconvolution algorithm, and all produced
CONTIN outputs with three distinct peaks for all experimental conditions. After 24 h of either paclitaxel treatment
or nutrient deprivation, the area-under-the-curve (AUC) of the first peak increased significantly while the AUC of
the third peak decreased significantly. These results lend strong support to the hypothesis that ACs acquired
from cells are composed of multiple components that correspond to light scattered by different subcellular struc-
tures and organelles. © The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or repro-
duction of this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.24.2.025002]
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1 Introduction
Speckle intensity in optical coherence tomography (OCT) is de-
pendent on the size, spatial distribution, shape, and optical prop-
erties of scatterers within a resolution volume (RV).1 In OCT
imaging of living samples, temporal fluctuations in speckle
intensity are observed due to scatterer motion,2 which can
include the flow of blood cells within vasculature, bulk move-
ment of organs and tissues, and intracellular motion (IM). IM is
the primary form of motion within in vitro cell samples that do
not have vasculature, and it can be divided into two categories:
passive and active motion. Passive motion refers to the random
Brownian motion experienced by subcellular structures and
organelles, and active motion refers to the deliberate motion
within cells necessary to complete cellular functions, such as the
transport of vesicles along microtubules and the morphological
changes associated with mitosis and cytokinesis. The intensity
fluctuations that arise from these movements can provide infor-
mation about a biological system, such as the effectiveness of
treatment on cancer cells.3
Dynamic light scattering (DLS) is a technique used to quan-
tify the movement of particles by analyzing the autocorrelation
(AC) function of light scattered by said particles.4 Generally,
an AC in DLS decays and the faster it decays, the greater
the average rate of motion within the sample.3 The integration
of DLS techniques with OCT is referred to as dynamic light
scattering optical coherence tomography (DLS-OCT) and was
first proposed as a method to spatially localize IM during
cell death. It has been demonstrated to have numerous biological
applications, such as imaging cerebral blood flow,5 observing
extracellular matrix remodeling in vitro,6 and measuring the
growth of biofilms.7 Lee et al.8 developed a model to represent
ACs from DLS-OCT that accounts for the finite size of voxels in
OCT and the fact that multiple scatterers can exist within a
voxel, each having a different rate of movement at any given
time. Their model represents the overall AC from an RV as
the superposition of individual ACs arising from each particle
in the RV, each of which can experience one of three types
of motion at any given time: static scatterers contribute to an
unchanging DC value in the AC, flowing and diffusing scatter-
ers contribute decaying terms, and particles moving in or out of
the RV contribute to a delta function.
Previously, Farhat et al.3 applied DLS-OCT to study changes
in IM in acute myeloid leukemia cells between 0 and 48 h after
treating the cells with cisplatin to induce apoptosis, a form of
programmed cell death. To compare ACs at different time
points, they defined a term known as the decorrelation time (DT)
as the time for an AC to decay to half its maximum value. They
observed that, 24 h after the start of treatment and persisting to
48 h, there was a significant decrease in DT, indicative of
increased IM.3 The increase in IM was likely caused by the mor-
phological changes that occur in apoptotic cells, such as round-
ing and shrinking of the cell, dissolution of the organelles, and
ultimately, the disintegration of the cell into smaller membrane-
bound fragments known as apoptotic bodies.9 However, an
analysis based solely on the overall DT does not provide insight
into the contributions of subcellular components to the mea-
sured signal.
In this work, we aim to use DLS-OCT to observe changes in
the rate of IM in breast cancer cells that have either been treated
with paclitaxel or deprived of nutrients and to gain insight into
the contributions of subcellular scatterers to the OCT signal*Address all correspondence to Michael C. Kolios, E-mail: mkolios@ryerson.ca
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using a deconvolution algorithm commonly used in DLS. We
hypothesize that the DTs acquired from paclitaxel-treated
cells will decrease after 24 h since paclitaxel is known to induce
apoptosis in breast cancer cells10 and apoptosis is characterized
by vigorous IM. Moreover, the structural changes associated
with apoptosis are consistent across different cell types.9
However, cells require energy in the form of ATP to undergo
apoptosis,11 and cells that are deprived of nutrients are rapidly
depleted of ATP. Instead of apoptosis, nutrient-deprived cells are
more likely to experience oncosis, which is a form of ischemic
or accidental cell death. Oncosis is characterized by predictable
changes in cellular morphology, including swelling of the cell
and rupture of the plasma membrane, ultimately causing intra-
cellular components to escape from the cell.9 We hypothesize
that the DTs acquired from nutrient-deprived cells will also
decrease due to increased passive IM.
Particles experiencing diffusive motion, such as the byprod-
ucts of apoptosis and oncosis, contribute to the DLS-OCTACs.8
Deconvolution algorithms can be used to decompose an AC into
component exponential decay functions, which is an ill-posed
problem as there can exist more than one mathematical solution
for a given AC. CONTIN is a deconvolution algorithm com-
monly used in DLS to determine the distribution of exponential
decay functions from polydisperse solutions containing particles
with different sizes and rates of diffusion.12 To overcome the ill-
posed nature of AC deconvolution and produce repeatable and
accurate outputs, CONTIN utilizes constraints on the relaxation
time distributions; this renders the algorithm less robust as it
requires prior knowledge (such as the range of scatterer sizes)
and cannot characterize an unknown system in a reliable
manner.12 The CONTIN output is a relaxation time distribution
that depicts the contribution of various exponential decay func-
tions to the overall AC as a function of decay time. The peaks in
the CONTIN output describe the contributions of populations of
light scatterers with similar sizes or diffusion rates to the overall
AC. The intracellular environment represents a polydisperse and
heterogeneous solution, and we hypothesize that when using
ACs acquired from DLS-OCT imaging of breast cancer cells
as input into the CONTIN algorithm, the distributions will
have multiple peaks that arise from the light scattered by various
subcellular structures, such as cellular nuclei and mitochondria.
2 Methods
2.1 Biological Sample Preparation
Cell samples were prepared from breast ductal carcinoma cells
(MCF-7). For each experimental trial, ∼2 × 107 cells were
grown in a 37°C incubator in a 75-cm2 cell culture flask con-
taining 10 mL of Dulbecco’s modified Eagle medium (DMEM)
containing 4.5 g∕L of glucose, and supplemented with 1%
streptomycin and penicillin, 10% fetal bovine serum, and 1%
insulin. The cells were separated evenly into three 75-cm2 cell
culture flasks 24 h prior to the start of any treatments, with each
flask containing ∼7 × 106 cells and the same concentration of
media and supplements as the initial flask but without insulin
as it inhibits MCF-7 sensitivity to paclitaxel.13
The three samples were left in the 37°C incubator for 24 h to
allow the cells to completely adhere to the bottom surface of the
flasks. After this time, two of the flasks were treated with
20 ng∕mL paclitaxel. The cells from the untreated sample were
made into a pellet and imaged at three different times: immedi-
ately after pellet formation, and then 24 and 48 h after pellet
formation. Between each time point, a small amount of phos-
phate-buffered saline (PBS) was added to the untreated cell pel-
let to keep the cells from drying out, and the pellet was stored at
37°C. The two samples that had been treated with paclitaxel
were imaged at one time point each, after 24 and 48 h of pacli-
taxel exposure, respectively, and then immediately discarded.
To form a pellet for imaging, all media was carefully
removed from a cell sample, which was then washed with
1× PBS. About 0.25% trypsin and ethylenediaminetetraacetic
acid were then applied to the sample for 5 min to suspend
cells that adhered to the surface of the flask and/or to each
other. The suspended cells were then placed into a small pellet
container and centrifuged at 500 g for 10 min to form a tightly
packed cylindrical pellet with a diameter of 8 mm and a height
of ∼0.6 to 0.8 mm.
2.2 Optical Coherence Tomography Data
Acquisition
OCT imaging was performed using a Thorlabs Inc. (Newton,
New Jersey) swept-source OCT system with a central wave-
length of 1310 nm, a bandwidth of 100 nm, and lateral and
axial resolutions of ∼25 and 12 μm, respectively. Each time
a sample was imaged, 500 consecutive two-dimensional frames
were recorded at a frame rate of 333 Hz, with each image span-
ning ∼1 mm in the transverse direction. Pixels in the images
were ∼10 μm × 10 μm in size. From each set of frames, a region
of interest (ROI) measuring 100 pixels in the transverse direc-
tion and 3 pixels in the axial direction was selected, starting
∼30 μm below the top surface of the cell pellet to avoid partial
volume effects. A sample b-mode OCT image and ROI selection
are shown in Fig. 1. For each pixel in the ROI, the intensity was
plotted as a function of time across all frames, and the AC was
calculated by taking the inverse Fourier transform of the power
spectrum of the intensity signal. The ACs from all 300 pixels
were then averaged, and the static component was subtracted
from the average AC to remove the contribution from static scat-
terers. The average AC from the ROI was then normalized to
have a maximum value of 1. To account for heterogeneity in
the cell pellets, each sample was imaged 10 times at different
spatial locations.
2.3 Autocorrelation Analysis
The mean ACs decayed to 50% of their maximum value within
two 3-ms time steps, so the DTwas not defined as the time for an
AC to decay to half its maximum value, as was done by Farhat
et al.3 Instead, all ACs were fitted to exponential decay curves,
and the DT for each AC was defined as the relaxation time of
the best-fit exponential decay curve.
Each measured AC was used as an input into the CONTIN
algorithm. We constrained the relaxation time distribution to be
within the range of 0.1 to 1000 ms. The upper limit of the range
was chosen to be >750 ms, which was the total length of each
AC, while the lower limit of the range was set to be significantly
less than the temporal resolution of our OCT system, which was
3 ms. The regularization parameter was initially set to 0 for a
pilot run, but the resulting relaxation time distribution was
noisy. The regularizer was then increased to 0.1 in a subsequent
trial run. The number of peaks and location of the peaks in the
distributions did not change when the regularizer was increased,
but the noise in the distributions was reduced significantly at
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the expense of slightly wider peaks so the regularizer was
chosen to be 0.1 for all AC deconvolution analysis.
2.4 Validation of Treatment Effectiveness
To confirm that the paclitaxel and nutrient-deprivation treat-
ments had an effect on the cells, ∼3 × 106 cells from one of
the experimental trials were evenly divided into three 25-cm2
cell culture flasks, each containing 5 mL of DMEM containing
4.5 g∕L of glucose and supplemented with 1% streptomycin
and penicillin and 10% fetal bovine serum. The cells were
then incubated at 37°C for 24 h to allow the cells to adhere
to the bottom surface of the flasks. After this time, the
confluence in all three flasks was close to 100%. About
20 ng∕mL paclitaxel was added to one of the flasks, the
media in another flask was replaced with 1× PBS, and the
third flask was used as a control group. All three flasks were
imaged with a standard light microscope, and then again
after 24 and 48 h to observe differences in the cells over
time after exposure to treatment.
3 Results and Discussion
The light microscopy images (Fig. 2) obtained from MCF-7 cell
samples showed significant changes in cellular morphology in
the paclitaxel-treated and nutrient-deprived groups but not in
the control group. After 24 h of paclitaxel exposure, sample
Fig. 1 (a) OCT b-mode image of an MCF-7 cell pellet. The ROI is indicated by the white rectangle. The
color bar indicates pixel image intensity between 0 and 255. The scale bar represents 0.25 mm.
(b) Diagram depicting the postprocessing pipeline used in this study to acquire DT and relaxation
time distribution from an ROI.
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confluence was reduced, and many suspended cells were
observed in the flask, which indicates loss of adherence and
which is a characteristic change that occurs during cell
death.14 Cells with irregular shapes were also observed, likely
indicative of membrane blebbing. After 48 h of paclitaxel expo-
sure, cell adherence was further reduced, and more irregularly
shaped cells were observed. In the nutrient-deprivation cell
group, adherence of the cells to the flask bottom was reduced
to 0% after 24 h. In contrast, there was no loss of confluence in
the control group after 24 or 48 h, and a very small number of
nonadherent cells were observed. Though these images do not
directly confirm the presence of cell death or differentiate
between different modes of cell death, they indicate a significant
treatment response in both the paclitaxel-treated and nutrient-
deprived cell groups.
ACs obtained from nutrient-deprived and paclitaxel-treated
cell samples are shown in Fig. 3. A significant drop is observed
in each of the ACs within the first 6 ms, which can be attributed
to scatterers moving in and out of RVs within the ROI. The
curves for the nutrient-deprived and paclitaxel-treated samples
decayed more rapidly than the curves for the untreated cell
samples, which indicates greater motion in the treated samples.3
Fig. 2 Bright-field microscopy images of control cells at (a) 0 h, (b) 24 h, and (c) 48 h; paclitaxel-treated
cells at (d) 0 h (pretreatment), (e) 24 h, and (f) 48 h; nutrient-deprived cells at (g) 0 h (pretreatment),
(h) 24 h, and (i) 48 h. The scale bar represents 0.2 mm.
Fig. 3 ACs obtained fromMCF-7 cell pellets (a) control and treated with 20 ng∕mL paclitaxel and (b) con-
trol and deprived of nutrients and growth factor. Each curve represents the average of 10 measurements
from within each sample.
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All experiments were performed in triplicate, on different weeks
and using different cell passages, and demonstrated good tech-
nique repeatability despite biological variations and inherent
heterogeneity between samples.
The DTs computed by fitting exponential decay curves to the
mean ACs are plotted as a function of treatment duration in
Fig. 4 to provide a quantitative assessment of the change in
AC decay as a function of treatment time. In all experimental
trials, a statistically significant drop in the DT (p < 0.01) was
observed after either 24 or 48 h of paclitaxel exposure or
nutrient-deprivation when compared to the untreated cell sam-
ples. However, there was no statistically significant difference
(p > 0.05) between the DTs from any of the treated groups,
suggesting that the technique could not distinguish between
the treatment types and durations used in these trials with the
approach presented. We hypothesize that both paclitaxel-treat-
ment and nutrient-deprivation lead to an increase in IM due to
structural changes that occur within the cells, and that many of
these changes occur within the first 24 h of treatment with a
diminishing effect within the next 24 h. Many active processes
that occur during apoptosis can lead to a net increase in the aver-
age rate of IM, including cytoskeletal restructuring and nuclear
and cellular fragmentation.9 Passive motion of intracellular com-
ponents or cell fragments can increase after apoptosis as well, as
the process reduces cells to fragmented bodies that are smaller
and can have greater diffusion compared to organelles in intact
cells. Oncosis results in cellular swelling and rupture that could
reduce steric hindrance and allow for organelles and particles to
diffuse more freely.9
A representative CONTIN output from one of the ACs
acquired from MCF-7 cells is shown in Fig. 5. A total of 150
ACs were used as input into CONTIN (30 each from untreated
cells, and 24- and 48-h paclitaxel-treated and nutrient-deprived
cells) and each produced an output with three distinct peaks,
which suggests that the ACs can be decomposed into three
main components. The mean central DTs of the peaks were
2.5 0.1 ms, 17.2 4.8 ms, and 223.6 23.5 ms. There
was no statistically significant difference (p > 0.05) between
the mean central DTs of the peaks between untreated samples
and those that had undergone various treatments.
To compare the CONTIN outputs from the different samples,
we computed the area-under-the-curve (AUC) of each of the
peaks for all CONTIN output distributions. For simplicity,
the peaks are referred to as P1, P2, and P3 in order of ascending
mean central DT. The AUCs of the three peaks as a function of
treatment type and duration are shown in Fig. 6. In both the
nutrient-deprived and paclitaxel-treated samples, a statistically
significant increase (p < 0.05) was observed in the AUC of P1
and a statistically significant decrease (p < 0.02) was observed
in the AUC of P3 after 24 or 48 h of treatment compared to the
control group. No statistically significant differences (p > 0.05)
Fig. 4 DTs obtained from MCF-7 cell pellets (a) deprived of nutrients and growth factors and (b) treated
with 20 ng∕mL paclitaxel, as a function of treatment duration. The 0-h measurements were taken prior to
treatment and represent a control DT. Each line represents a separate experiment (three in total).
Error bars represent the standard deviation across 10 separate measurements at different locations
from within each sample.
Fig. 5 Sample CONTIN outputs depicting the contribution of various
exponential decay functions to the AC as a function of their DTs. The
solid line depicts a representative sample CONTIN output from an
untreated cell sample while the dashed line depicts a representative
sample CONTIN output from 48-h nutrient-deprived cells.
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were observed in the AUC of P2 between any groups, or in the
AUCs of P1 and P3 between any of the treated groups.
The values generated using the ACs as input into the
CONTIN algorithm can be used to differentiate between the
treated and untreated cells based on changes in the AUCs of
P1 and P3. Experiments demonstrated good technique repeat-
ability. Though fitting a single exponential decay curve to
each AC was sufficient for differentiating the ACs and
correlating these to treatment response, we believe that the val-
ues produced using the CONTIN algorithm may provide more
detailed information about scattering structures in the cells stud-
ied. We speculate that each of the three peaks in the CONTIN
output distributions arose from light scattered by different intra-
cellular components. Since P1 had a central DTof 2.5 0.1 ms,
which is smaller than the temporal resolution of our system
(3 ms), we suspect that these results related to P1 may have
Fig. 6 AUC of P1 in (a) nutrient-deprived cells and (b) paclitaxel-treated cells as a function of treatment.
AUC of P2 in (c) nutrient-deprived cells and (d) paclitaxel-treated cells as a function of treatment. AUC of
P3 in (e) nutrient-deprived cells and (f) paclitaxel-treated cells as a function of treatment. Box plot whisk-
ers show the minimum and maximum values in each group. The central line within the box plots is the
group median. The top and bottom limits of the boxes are the 75th and 25th percentiles, respectively.
Each box represents a group of 30 measurements. No outliers were detected. *p ≪ 0.01.
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primarily arisen from a combination of light backscattered by
very small structures, such as lysosomes and vesicles, which
would have rapid diffusive motion. Small particles of this
size range are expected to move in and out of the RV for the
timescales measured. Other significant scattering structures
within cells include mitochondria15 and nuclei,16 and we suspect
that they may have been the dominant scattering structures that
contributed to P2 and P3, respectively. We speculate that the
increase in the AUC for P1 that occurs after both treatments
is caused by the breakdown of larger structures into smaller
structures, and an increase in the motion in and out of each
RV. Furthermore, we speculate that the decrease in the AUC
of P3 may have arisen from the breakdown of nuclei, resulting
in such structures scattering less light and therefore contributing
less to the AC.
4 Conclusions
We have shown through this work that DLS-OCT techniques
can be used to differentiate between untreated and treated
MCF-7 breast cancer cells 24 h after the start of treatment
for two different types of treatments, with good repeatability.
However, our techniques could not distinguish between the
different types of cell death at the 24- or 48-h timepoints using
this approach. Further investigation of the ACs within the first
24 h of treatment to test for differences between the chemo-
therapy-treated and nutrient-deprived groups, with better tempo-
ral resolution to determine greater differences in changes in the
ACs, is the subject of future work.
This work presents the first time the CONTIN deconvolution
algorithm was used to characterize ACs from in vitro cell sam-
ples as superpositions of multiple exponential decay functions.
The results were reproducible across three separate trials, evi-
dencing the effectiveness of the technique for the study of
MCF-7 cell pellets. However, it should be noted that cell pellets
are rather simple systems compared to in vivo models because
they are relatively motionless on an extracellular level. In living
animals or humans, the presence of bulk motion, blood flow,
respiration, or other types of movement could affect the fluctu-
ating OCT signal; these additional sources of movement could
contaminate the ACs with noise or artifacts that could render
CONTIN less effective. We anticipate that corrections would
have to be performed on DLS data acquired in vivo to account
for these additional factors.
Future work should aim to concurrently perform DLS-OCT
while also quantifying the motion of light-scattering organelles,
such as nuclei and mitochondria, using methods such as confo-
cal microscopy. This may provide a better understanding of the
relationship between the IM of specific intracellular targets and
the AC decay. Furthermore, investigation into the motion of
individual scatterers may provide insights related to the origin
of the three peaks observed in the CONTIN output distributions
and what intracellular structures contribute to these peaks.
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